VPVilma Pacheco-Barcia

Vilma Pacheco-Barcia

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Vilma Pacheco-Barcia has a total of 141 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Imposter Syndrome, Burnout, and Maladaptive Perfectionism Among Oncology Professionals: A Global Cross-Sectional Study

    by Enes Erul, Vilma Pacheco-Barcia, Ali Alkan, Erman Akkus, Furkan Berk Danisman, Ioanna Nixon, Alexandru Eniu, Yuksel Urun

    PURPOSE: This study aimed to examine the prevalence and predictors of imposter syndrome (IS), burnout, and maladaptive perfectionism (MP) among oncology professionals to better understand their inter-relations and impact on clinician well-being. METHODS: A global cross-sectional survey was conducted with oncology professionals across 55 countries. Participants completed validated scales: Clance Impostor Phenomenon Scale (CIPS), Maslach Burnout Inventory, and Short Almost Perfect Scale (SAPS). Sociodemographic and occupational data were analyzed. Multivariate regression using a causal framework explored the controlled direct effects (CDEs) and natural direct effects on burnout. RESULTS: Among 542 participants, 34.1% had high CIPS scores, 56.1% met criteria for burnout, and 38% were identified as maladaptive perfectionists. Younger age ( P = .006), female sex ( P = .001), and not having children ( P = .007) were associated with high CIPS scores. Burnout was most prevalent among participants younger than 40 years, particularly those younger than 30 years (64.6%) and age 30-39 years (58.3%; P = .010). Longer working hours were significant predictors of higher burnout rates ( P < .001). In the CDE analyses, higher CIPS and greater SAPS-Discrepancy increased burnout risk ( P < .001); higher SAPS-Standards ( P < .001), higher academic title ( P ≤ .044), private hospital setting ( P = .010), and higher income ( P < .001) reduced burnout risk. Parenthood ( P = .013) and formal/semiformal mental health training ( P < .001) were protective. The CDE for age was nonsignificant ( P = .495): any apparent protective effect of age operates primarily through indirect (mediated) pathways. CONCLUSION: Burnout is prevalent among oncology professionals, with contributions from both structural factors and psychological pathways. In our European-centric cohort, higher impostor phenomenon (CIPS) and greater perfectionistic discrepancy (SAPS) increased burnout risk, especially in early-career clinicians. Therefore, targeted, evidence-based interventions that pair structural measures are warranted to reduce excessive workload with brief skill programs that address imposter cognitions and discrepancy while preserving high standards.


  • Open Access

    Prognostic modeling of overall survival in metastatic pancreatic cancer: an inflammation-based tool validated in PANTHEIA-SEOM cohort

    by Vilma Pacheco-Barcia, Axel Mariño-Mendez, María Ángeles Vicente Conesa, María de Toro Carmena, Paula Cerdà Serdà, Carmen Guillen-Ponce, Mónica Benavente Lucas, Raquel Hernández San Gil, Ángela Lamarca, Javier Gallego, et al.

    Purpose: To develop and internally validate the PANTHEIA-SIRI prognostic model, which integrates log-transformed systemic inflammation response index (SIRI) with clinical predictors, to estimate overall survival (OS) in metastatic pancreatic ductal adenocarcinoma (mPDAC) treated with first-line chemotherapy. Methods: We used data from the multicenter PANTHEIA-SEOM registry. OS was defined from chemotherapy start. The model was fitted as a Weibull accelerated failure time model in the survival-analysis population with multiple imputation. Predictors were log-transformed baseline SIRI, modeled with restricted cubic splines, ECOG, tumor burden, chemotherapy regimen, and anorexia-cachexia syndrome. Internal validation used a separate, non-overlapping cohort from the same registry; the centers contributing to each cohort are listed in a supplementary annex. TRIPOD was followed. Discrimination was assessed with Harrell´s C-index and calibration with IPCW Brier scores and IPA. Results: The derivation cohort comprised 672 patients with SIRI data (593 analyzed for survival) across 22 Spanish hospitals (2015–2025); 80.1% had died after a median OS of 9.9 months. The imputation-pooled derivation C-index was 0.654 (95% CI, 0.627–0.681); optimism-corrected, 0.629. Internal validation used 62 separate patients from the same registry; 96.8% had died after a median OS of 9.2 months. The validation C-index was 0.603 (95% CI, 0.518–0.687). Calibration was adequate at 6 and 12 months. Conclusions: The PANTHEIA-SIRI model provides individualized OS estimates in mPDAC with routine clinical predictors. Its open-access calculator ( https://pantheia-siri.shinyapps.io/calc/ ) may support prognostic communication, treatment-intensity selection, and supportive-care planning. Routine clinical implementation will require further validation in larger, fully independent cohorts.


  • Open Access

    Systemic inflammation response index (SIRI) predicts outcomes and chemotherapy benefit in metastatic pancreatic cancer: A study by the PANTHEIA- SEOM group

    by Alberto Carmona-Bayonas, Axel Mariño Méndez, María Ángeles Vicente-Conesa, Paula Jimenez-Fonseca, María de Toro Carmena, Carmen Guillen-Ponce, Angela Lamarca, Mónica Benavente, Javier Gallego, Paula Cerdà Serdà, et al.


  • Open Access

    Interventional strategies to address burnout in young medical oncologists: results from the Resilience-Spanish Society of Medical Oncology (SEOM) Study and a university hospital experience in Spain

    by Vilma Pacheco-Barcia, Berta Obispo, Elia Tomas, Clara Salva de Torres, Teresa Quintanar, David Paez, Luis Leon-Mateos, Hernan Cancio, Alexandra Cortegoso, Urbano Anido, et al.

    Purpose Burnout syndrome is an increasingly prevalent problem among young oncologists with a prevalence of up to 71% of physicians in Europe, with potential personal and professional consequences. Few studies have been conducted to evaluate the best primary prevention or interventional strategy to reduce burnout levels. The aim of our study was to determine the efficacy of a therapy. Patients and methods The Resilience-SEOM study was carried out by the + MIR section, which involved three training workshops organized to improve coping and communication skills in a pilot sample of medical oncology residents. On the other hand, the Group Psychotherapy (GP) program was carried out with the mentor of residents of the Oncology Department at the Vall D´Hebron University Hospital, providing a therapeutic space of 1 h per month from September 2023 to June 2024. Participants in both studies completed the Maslach Burnout Inventory Human Services Survey (MBI-HSS) at the beginning and at the end of the programs. Results The results indicate that there was no significant difference in the average initial MBI score, although a trend toward a decrease in burnout levels was observed. The % of participants of workshops with a high level of personal achievement increased from 5 to 25%, the difference being statistically significant (p = 0.002). The results of the GP program show that the difference in the overall pre- and post-intervention scores was statistically significant (0.029). Conclusion In the Resilience-SEOM study, communication skills workshops as an interventional strategy mitigated burnout levels in medical oncology residents, mainly by improving personal achievement. GP as an interventional strategy for burnout could be feasible to address the emotional impact of burnout.


  • Open Access

    Immune-checkpoint inhibitor resistance in patients with cancer

    by Luis Cabezón-Gutiérrez, Sara Custodio-Cabello, Magda Palka-Kotlowska, Beatriz Chacón-Ovejero, Vilma Pacheco-Barcia

    The introduction of immune checkpoint inhibitors (ICIs) has transformed the landscape of oncology, offering significant improvements in patient survival and achieving remarkable long-term outcomes. Despite these advances, the therapeutic benefits of ICIs are not universal, and existing biomarkers often fall short in accurately predicting patient responses. A comprehensive understanding of the mechanisms underlying resistance to ICIs is essential for the development of strategies to mitigate these challenges and enhance therapeutic efficacy. This review provides a detailed exploration of the resistance mechanisms associated with ICIs, focusing on the role of the tumor microenvironment and intrinsic tumor cell alterations in mediating both primary and secondary resistance. Furthermore, it evaluates emerging strategies to overcome resistance, including combination therapies and innovative therapeutic approaches. By dissecting the molecular and immunological pathways implicated in ICI resistance, this review aims to highlight novel predictive and prognostic biomarkers and outline optimized therapeutic strategies to maximize the clinical impact of ICIs in cancer management.


  • Open Access

    Influencia de la dignidad percibida y estrategias de afrontamiento en la incertidumbre y malestar emocional de pacientes con cáncer avanzado

    by Berta Obispo Portero, Paula Jiménez-Fonseca, Teresa García-García, Jacobo Rogado, Vilma Pacheco-Barcia, Caterina Calderon

    Objetivo: en este análisis evaluaremos el malestar psicológico al diagnóstico del cáncer avanzado, la dignidad percibida y su relación con factores sociodemográficos, clínicos y psicológicos, así como las estrategias de afrontamiento como moduladoras entre la incertidumbre y el malestar psicológico. Método: este estudio se fundamentó en el proyecto NEOetic, un registro prospectivo y multicéntrico promovido por la sección de Bioética de la Sociedad Española de Oncología Médica (SEOM). Se utilizaron diversas escalas: BSI-18, PPDS, MUIS, DUFSSQ y MINI-MAC. Además, se analizaron factores sociodemográficos y clínicos y su relación con el resto de variables. Resultado: los pacientes tratados durante la pandemia de Covid-19 mostraban altos niveles de ansiedad y depresión, especialmente vinculados a ser joven al diagnóstico, tener una expectativa de vida superior a 18 meses: al sexo femenino, tener preocupación por el cáncer y experimentar desesperanza. Aquellos con bajos niveles de dignidad percibida mostraron mayor ansiedad y depresión, y una actitud menos positiva. El malestar psicológico afectó al 72% de los pacientes, siendo la actitud positiva y la evitación cognitiva las estrategias de afrontamiento más empleadas. Conclusiones: estos hallazgos subrayan la importancia de abordar la salud mental de los pacientes oncológicos especialmente en situaciones de crisis como la pandemia. Es esencial promover estrategias de afrontamiento eficaces y proporcionar un apoyo emocional adecuado. Se recomienda a los oncólogos realizar evaluaciones periódicas del estado psicológico de sus pacientes, adaptando intervenciones personalizadas que respondan a los factores identificados para reforzar la resiliencia emocional y mejorar la calidad de vida de los pacientes.

  • Open Access

    Complete response to third-line treatment with trifluridine/tipiracil (TAS-102) in stage IV colon adenocarcinoma

    by Celia Lara-Morga, Magda Palka-Kotlowska, Sara Custodio-Cabello, Vilma Pacheco-Barcia, Luis Cabezón-Gutiérrez

    A clinical case of a 61-year-old female diagnosed with stage IV right colon adenocarcinoma (unresectable liver and multiple lymph node metastases at the time of diagnosis), Kirsten rat sarcoma viral


  • Open Access

    The AGAMENON-SEOM model for prediction of survival in patients with advanced HER2-positive oesophagogastric adenocarcinoma receiving first-line trastuzumab-based therapy

    by Paula Jimenez-Fonseca, Victoria Foy, Sophie Raby, Alberto Carmona-Bayonas, Lola Macía-Rivas, Virginia Arrazubi, Diego Cacho Lavin, Raquel Hernandez San Gil, Ana Custodio, Juana María Cano, et al.

    Background: Trastuzumab and chemotherapy is the standard first-line treatment in human epidermal growth factor receptor 2 (HER2)-positive advanced gastro-oesophageal cancer. The objective was to develop a predictive model for overall survival (OS) and progression-free survival (PFS) in patients treated with trastuzumab. Methods: Patients with HER2-positive advanced gastro-oesophageal adenocarcinoma (AGA) from the Spanish Society of Medical Oncology (SEOM)-AGAMENON registry and treated first line with trastuzumab and chemotherapy between 2008 and 2021 were included. The model was externally validated in an independent series (The Christie NHS Foundation Trust, Manchester, UK). Results: In all, 737 patients were recruited (AGAMENON-SEOM, n = 654; Manchester, n = 83). Median PFS and OS in the training cohort were 7.76 [95% confidence interval (CI), 7.13–8.25] and 14.0 months (95% CI, 13.0–14.9), respectively. Six covariates were significantly associated with OS: neutrophil-to-lymphocyte ratio, Eastern Cooperative Oncology Group performance status, Lauren subtype, HER2 expression, histological grade and tumour burden. The AGAMENON-HER2 model demonstrated adequate calibration and fair discriminatory ability with a c-index for corrected PFS/OS of 0.606 (95% CI, 0.578–0.636) and 0.623 (95% CI, 0.594–0.655), respectively. In the validation cohort, the model is well calibrated, with a c-index of 0.650 and 0.683 for PFS and OS, respectively. Conclusion: The AGAMENON-HER2 prognostic tool stratifies HER2-positive AGA patients receiving trastuzumab and chemotherapy according to their estimated survival endpoints.


  • Open Access

    Role of sex on psychological distress, quality of life, and coping of patients with advanced colorectal and non-colorectal cancer

    by Vilma Pacheco-Barcia, David Gomez, Berta Obispo, Luka Mihic Gongora, Raquel Hernandez San Gil, Patricia Cruz-Castellanos, Mireia Gil-Raga, Vicente Villalba, Ismael Ghanem, Paula Jimenez-Fonseca, et al.

    Patients with advanced gastrointestinal cancer must cope with the negative effects of cancer and complications. To evaluate psychological distress, quality of life, and coping strategies in patients with advanced colorectal cancer compared to non-colorectal cancer based on sex. A prospective, transversal, multicenter study was conducted in 203 patients; 101 (50%) had a colorectal and 102 (50%) had digestive, non-colorectal advanced cancer. Participants completed questionnaires evaluating psychological distress (Brief Symptom Inventory-18), quality of life (EORTC QLQ-C30), and coping strategies (Mini-Mental Adjustment to Cancer) before starting systemic cancer treatment. The study included 42.4% women. Women exhibited more depressive symptoms, anxiety, functional limitations, and anxious preoccupation than men. Patients with non-colorectal digestive cancer and women showed more somatization and physical symptoms than subjects with colorectal cancer and men. Men with colorectal cancer reported the best health status. The degree of disease acceptance in gastrointestinal malignancies may depend on sex and location of the primary digestive neoplasm. Future interventions should specifically address sex and tumor site differences in individuals with advanced digestive cancer.


  • Open Access

    Psychological distress and resilience in patients with advanced cancer during the Covid-19 pandemic: the mediating role of spirituality

    by Luka Mihic-Gongora, Paula Jiménez-Fonseca, Raquel Hernandez, Mireia Gil-Raga, Vilma Pacheco-Barcia, Aránzazu Manzano-Fernández, Susana Hernando-Polo, Mónica Antoñanzas-Basa, María J. Corral, María Valero-Arbizu, et al.

    Background: The purpose of this study was to investigate the sociodemographic factors related to psychological distress, spirituality, and resilience, and to examine the mediating role of spirituality with respect to psychological distress and resilience in patients with advanced, unresectable cancer during the Covid-19 pandemic. Methods: A prospective, cross-sectional design was adopted. Data were collected from 636 participants with advanced cancer at 15 tertiary hospitals in Spain between February 2019 and December 2021. Participants completed self-report measures: Brief Resilient Coping Scale (BRCS), Brief Symptom Inventory (BSI-18), and Spiritual well-being (FACIT-Sp). Hierarchical linear regression models were used to explore the mediating role of spirituality. Results: Spirituality was significantly different according to the person’s age and marital status. Psychological distress accounted for 12% of the variance in resilience (β = − 0.32, p < 0.001) and spirituality, another 15% (β =0.48, p < 0.001). Spirituality acted as a partial mediator in the relationship between psychological distress and resilience in individuals with advanced cancer. Conclusions: Both psychological distress and spirituality played a role in resilience in cases of advanced cancer. Spirituality can help promote subjective well-being and increased resilience in these subjects.